Literature DB >> 11988335

Focal encephalitis in the Lewis rat induced by intracerebral enterotoxin superantigen and amplified by activated intravenous splenocytes.

Malte E Kornhuber1, Caroline Ganz, Roland Lang, Thomas Brill, Wolfgang Schmahl.   

Abstract

The histological response after intracerebral (IC) injection of superantigen (SAg) was investigated in unprimed Lewis rats. The staphylococcal enterotoxins (SE) A (SEA), and E, but not B or saline, induced a variable perivascular inflammation in the injected hemisphere (6.7 +/- 6.1 cuffs per tissue section with SEA; mean +/- SD). Adoptive transfer of mitogen activated splenocytes (AS) augmented the response to SEA significantly (18.5 +/- 11.4; P<0.05). With or without AS transient bilateral perivascular cuffs were observed around the ventricles and in the corpus callosum up to 3 days after IC injection. The findings demonstrate that local expression of SAg in the brain can cause encephalitis, depending on the number of activated T cells in the circulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988335     DOI: 10.1016/s0304-3940(02)00107-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  [Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept].

Authors:  M E Kornhuber; S Zierz
Journal:  Nervenarzt       Date:  2003-05-14       Impact factor: 1.214

2.  [Noninflammatory pathogenesis of lesions in multiple sclerosis].

Authors:  M E Kornhuber
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

3.  [Retrovirus superantigen hypothesis of multiple sclerosis].

Authors:  A Emmer; M S Staege; M E Kornhuber
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

Review 4.  The retrovirus/superantigen hypothesis of multiple sclerosis.

Authors:  Alexander Emmer; Martin S Staege; Malte E Kornhuber
Journal:  Cell Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.